Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2677

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2413 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

24 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LORAZEPAM 0.5MG TABLET Resolved 2022-12-08 2023-04-28 177523
TEVA-LORAZEPAM 2MG TABLET Resolved 2022-12-08 2023-06-09 177526
TEVA-LOPERAMIDE 2MG TABLET Resolved 2018-03-13 2018-05-30 42591
TEVA-LOPERAMIDE 2MG TABLET Resolved 2018-03-13 2018-05-30 42594
TEVA-LOPERAMIDE 2MG TABLET Resolved 2020-06-25 2020-07-23 118925
TEVA-LOPERAMIDE 2MG TABLET Resolved 2022-07-25 2022-10-01 165441
TEVA-LOPERAMIDE 2MG TABLET Resolved 2023-07-18 2023-07-21 198957
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 10MG TABLET Resolved 2019-10-31 2020-05-01 97622
TEVA-LISINOPRIL/HCTZ (TYPE Z) 12.5MG 20MG TABLET Resolved 2019-10-31 2020-09-24 97625
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2019-10-31 2020-04-23 97628
TEVA-LISINOPRIL/HCTZ (TYPE Z) 10MG 12.5MG TABLET Resolved 2020-05-08 2020-12-03 114427
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 25MG TABLET Resolved 2020-09-24 2020-11-26 124983
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 25MG TABLET Resolved 2020-10-30 2020-12-03 127625
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 12.5MG TABLET Resolved 2020-11-06 2021-02-05 128016
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 12.5MG TABLET Resolved 2020-11-06 2020-12-18 128049
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 25MG TABLET Resolved 2020-12-17 2020-12-18 130313
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 12.5MG TABLET Resolved 2021-01-07 2021-03-25 131087
TEVA-LISINOPRIL/HCTZ (TYPE Z) 20MG 25MG TABLET Resolved 2021-01-07 2021-01-14 131090
TEVA-LISINOPRIL/HCTZ (TYPE Z) 10MG 12.5MG TABLET Resolved 2021-01-15 2021-02-05 131700
TEVA-LISINOPRIL/HCTZ (TYPE Z) 25MG 20MG TABLET Resolved 2023-02-02 2023-02-16 183398

Showing 1081 to 1100 of 2677

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-OLMESARTAN 40MG TABLET Discontinued 2020-06-11 2020-06-11 117500
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-10-25 2019-10-26 97256
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-01-24 2020-01-24 104277
ACT NABILONE 1MG CAPSULE Discontinued 2019-10-31 2019-11-01 97581
ACT NABILONE 0.5MG CAPSULE Discontinued 2020-10-15 2020-10-15 126452
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
TEVA-LEVETIRACETAM 500MG TABLET Discontinued 2020-01-24 2020-01-24 104304
ACT ETIDROCAL 400MG 500MG TABLET Discontinued 2019-02-21 2019-03-01 76486
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
ACT DONEPEZIL ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-10-19 2018-10-19 64872
ACT DONEPEZIL ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-10-19 2018-10-19 64875
ACT DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115114
ACT DILTIAZEM T 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115117
ACT DILTIAZEM T 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115120
ACT DILTIAZEM T 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115123
ACT DILTIAZEM T 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-05-14 2020-05-14 115126

Showing 221 to 240 of 250